不同剂量羟考酮缓解甲状腺术后气管拔管反应的比较

doi:10.12092/j.issn.1009-2501.2019.11.012

中国临床药理学与治疗学 ›› 2019, Vol. 24 ›› Issue (11): 1287-1292.doi: 10.12092/j.issn.1009-2501.2019.11.012

不同剂量羟考酮缓解甲状腺术后气管拔管反应的比较

李佳佳¹，盛毅²，黄梦朦¹，韩园¹，朱纯纯¹，刘华程¹，李军¹

¹温州医科大学附属第二医院麻醉科，温州 325027，浙江； ²温州医科大学第二临床医学院，温州 325035，浙江

收稿日期:2019-07-22 修回日期:2019-09-30 出版日期:2019-11-26 发布日期:2019-12-02
通讯作者: 李军，男，博士，主任医师，硕士生导师，研究方向：麻醉药理学。 Tel：13587415215 E-mail：lijun0068@163.com
作者简介:李佳佳，女，硕士，住院医师，研究方向：临床麻醉。 Tel：18267727779 E-mail：ljj1568@163.com
基金资助:
浙江省自然科学基金一般项目（LY17H310006）

Comparison of responses induced by tracheal extubation between different doses of oxycodone after thyroidectomy

LI Jiajia¹, SHENG Yi², HUANG Mengmeng¹, HAN Yuan¹, ZHU Chunchun¹, LIU Huacheng¹, LI Jun¹

¹Department of Anesthesiology, Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027,Zhejiang, China; ²The Second Clinical Medical College of Wenzhou Medical University, Wenzhou 325035, Zhejiang, China

Received:2019-07-22 Revised:2019-09-30 Online:2019-11-26 Published:2019-12-02

摘要/Abstract

摘要：

目的:比较不同剂量羟考酮对甲状腺手术患者全麻恢复期气管拔管反应的影响。方法:选取80例择期行甲状腺手术的患者，随机分为四组。四组患者接受统一麻醉诱导及维持用药方案，手术结束前20～40 min分别静推0.05 mg/kg羟考酮（Q1）、0.1 mg/kg羟考酮（Q2）、0.15 mg/kg羟考酮（Q3）和等容积生理盐水（C）。记录四组患者麻醉诱导前（T0）、拔管时（T1）、拔管后5 min（T2）、拔管后10 min（T3）的平均动脉压（MAP）、心率（HR）和自主呼吸恢复时间、苏醒时间、拔管时间、拔管时的呛咳反应与程度，以及入恢复室后5 min、15 min、30 min警觉/镇静评分、视觉模拟评分（VAS）及药物不良反应。结果:与T0相比，C、Q1组患者在T1、T2时点MAP升高、HR加快（P<0.05），而Q2、Q3组T1～T3时点的差异无统计学意义（P>0.05）；与C组相比，Q1组患者MAP、HR的差异无统计学意义（P>0.05），Q2、Q3组的差异有统计学意义（P<0.05）。与C组相比，Q2、Q3组患者气管拔管时的呛咳反应明显缓解（P<0.05），Q3组患者自主呼吸恢复时间和拔管时间延长（P<0.05），三羟考酮组患者在麻醉后监测治疗室（PACU）的VAS评分明显下降（P<0.05）。结论:手术结束前20～40 min应用羟考酮可减轻甲状腺手术患者全麻恢复期的气管拔管反应，且0.1 mg/kg羟考酮为最适剂量，效果显著，术后镇痛效果良好，不良反应少，更安全。

关键词: 羟考酮, 甲状腺切除术, 气管拔管反应

Abstract:

AIM:To investigate the differences of the reaction induced by tracheal extubation between different doses of oxycodone after thyroidectomy. METHODS: After the unified anesthesia induction and maintenance regimen, eighty patients undergoing elective thyroidectomy were randomly divided into four groups receiving 0.05 mg/kg (group Q1), 0.1 mg/kg (group Q2), 0.15 mg/kg(group Q3) of intravenous oxycodone, or the same capacity of normal saline(group C) at 20-40 min before the end of surgery. MAP and HR were measured before anesthesia induction (T0), immediately after extubation(T1), at 5(T2) and 10 min(T3) after extubation. The recovery time of postoperative spontaneous breathe, awakening time, extubated time and the cough reflex caused by extubation were recorded. In addition, the OAA/S and VAS scores were marked at 5 min, 15 min, 30 min after entering the recovery room. RESULTS:Compared with T0, MAP and HR of group C and Q1 at T1, T2 increased significantly (P<0.05), while those of group Q2 and Q3 had no differences (P>0.05). Compared with group C, MAP and HR in group Q2, Q3 were lower (P<0.05) while those of group Q1 had no differences (P>0.05); the cough reflex of group Q2 and Q3 were lighter (P<0.05); the patients in group Q3 had the longer recovery time of postoperative spontaneous breathe and extubated time(P<0.05). Also, the VAS scores in PACU of three Q groups were lower than group C(P<0.05). CONCLUSION:Oxycodone administered at 20-40 min before the end of surgery can alleviate responses induced by extubation of the patients after thyroidectomy. 0.1 mg/kg of intravenous Oxycodone is the best dose for it can offer a better quality of recovery and postoperative analgesia with the fewer side effects.

Key words: oxycodone, thyroidectomy, responses of extubation

中图分类号:

李佳佳，盛毅，黄梦朦，韩园，朱纯纯，刘华程，李军. 不同剂量羟考酮缓解甲状腺术后气管拔管反应的比较[J]. 中国临床药理学与治疗学, 2019, 24(11): 1287-1292.

LI Jiajia, SHENG Yi, HUANG Mengmeng, HAN Yuan, ZHU Chunchun, LIU Huacheng, LI Jun. Comparison of responses induced by tracheal extubation between different doses of oxycodone after thyroidectomy[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(11): 1287-1292.

参考文献

［1］刘若海, 韩园, 刘启星, 等.右美托咪定复合瑞芬太尼对全麻气管拔管反应的影响［J］.中国临床药理学与治疗学,2015,20(7):789-792.
［2］袁晓红, 连燕虹, 方军, 等.盐酸羟考酮注射液对腹腔镜全麻患者苏醒及血流动力学的影响［J］.中国全科医学杂志,2017,15(12):2042-2044.
［3］Pandey CK, Chandra K, Mehdi M, et al. Intravenous lidocaine suppresses fentanyl-induced coughing: a double-blind, prospective, randomized placebo-controlled study［J］.Anesth Analg, 2004,99(6):1696-1698.
［4］Chernik DA, Gillings D, Laine H, et al. Validity and reliability of the observers assessment of alterness/sedation scale：study with intravenous midazolam［J］.J Clin Psychopharmacol,1990, 10(4):244-251.
［5］Sun L, Guo R, Sun L. Dexmedetomidine for preventing sevflurane-related mergence agitaion in children: a meta-analysis of randomized controlled trials［J］.Acta Scand,2014,58(6):642-650.
［6］Han L, Su Y, Xiong H, et al. Oxycodone versus sufentanil in adult patient-controlled intravenous analgesia after abdominal surgery: A prospective, randomized, double-blinded, multiple-center clinical trial［J］.Medicine,2018,97 (31):e11552.
［7］李鑫, 吴秀英.羟考酮与舒芬太尼用于腹腔镜辅助全子宫切除术术后镇痛的效果比较［J］.中国医科大学学报, 2019, 48(5): 442-445.
［8］孙加晓, 杨雅婷, 谢文吉, 等.羟考酮、舒芬太尼和芬太尼用于术后镇痛对结肠癌患者免疫功能的影响［J］.临床麻醉学杂志, 2018, 34(5): 421-424.
［9］Kim NS, Lee JS, Park SY, et al. Oxycodone versus fentanyl for intravenous patient-controlled analgesia after laparoscopic supracervical hysterectomy［J］.Medicine,2017,96 (10):e6286.
［10］Lenz H, Sandvik L, Qvigstad E, et al. A comparison of intravenous oxycodone and intravenous morphine in patient-controlled postoperative analgesia after laparoscopichysterectomy［J］.Anesth Analg 2009,109(4):1279-1283.
［11］刘清仁, 余健, 王淼, 等.羟考酮在腹腔镜全子宫切除术后镇痛中的应用［J］.临床麻醉学杂志, 2019, 35(1): 38-41.
［12］许幸, 吴新民, 薛张纲, 等.盐酸羟考酮注射液用于全麻患者术后镇痛的有效性和安全性［J］.中华麻醉学杂志, 2013, 3(33): 269-274.
［13］朱亚军, 罗武平, 黄振杰, 等.盐酸羟考酮注射液对腹腔镜下肠癌根治术老年患者全麻苏醒的影响［J］.临床合理用药, 2018, 11(1A): 93-94.
［14］白艳辉, 李爱军.羟考酮注射液在宫颈癌腹腔镜术后苏醒期镇痛中的应用［J］.临床合理用药, 2018, 46(4): 464-465.
［15］朱冰青，韩明明，瞿明玉，等.盐酸羟考酮对烟雾病血管重建术患者全麻苏醒期恢复质量的影响［J］.中国临床药理学与治疗学, 2019, 24(8): 928-932.
［16］Chung KS, Sinatra RS, Halevy JD, et al. A comparison of fentanyl, esmolol, and their combination for blunting the haemodynamic responses during rapid-sequence induction［J］.Can J Anaesth,1992,39(8):774-779.
［17］徐建国.盐酸羟考酮的药理学和临床应用［J］.临床麻醉学, 2014, 30(5): 511-513.
［18］唐作垒, 吴畏.盐酸羟考酮预防麻醉诱导中芬太尼诱发患者咳嗽的效果［J］.中华麻醉学杂志, 2014, 34(6):668-669.
［19］李运, 秦美满, 方波.右美托咪定联合盐酸羟考酮对胃肠手术老年患者麻醉苏醒期的影响［J］.中国新药杂志,2016,25(8):903-907.
［20］于翠萍, 范婷, 王培.不同剂量盐酸羟考酮对患者自主呼吸及意识的影响［J］.医药导报,2017,36(8):905-908.

[1]	周俊辉，孟宪慧. 序贯法测定羟考酮皮下注射用于Stanford A型主动脉夹层撕裂患者术前镇痛的半数有效剂量[J]. 中国临床药理学与治疗学, 2019, 24(8): 916-921.
[2]	朱冰青，韩明明，翟明玉，杨佳，李娟. 盐酸羟考酮对烟雾病血管重建术患者全麻苏醒期恢复质量的影响[J]. 中国临床药理学与治疗学, 2019, 24(8): 928-932.
[3]	徐丽丽，王云甫，全变瑞. 盐酸羟考酮控释片复合窄谱中波紫外线治疗带状疱疹神经痛的疗效[J]. 中国临床药理学与治疗学, 2018, 23(3): 333-336.
[4]	王俊，蒋宗明，郑君刚，曹刚，黄长顺，卢子会，季一勤. 右美托咪定复合盐酸羟考酮术后镇痛对胃肠肿瘤病人睡眠质量的影响[J]. 中国临床药理学与治疗学, 2018, 23(2): 165-169.
[5]	钱祖超, 张群, 罗华梁. 盐酸羟考酮用于腹腔镜直肠癌根治术患者镇痛效果的观察[J]. 中国临床药理学与治疗学, 2015, 20(5): 587-590.
[6]	张志永, 贾乃光, 黄文起, 黄宇光, 刘薇, 冷金花, 高雪松, 杨扬, 张亚军, 刘春霞, 曹雷, 林世清. 口服氨酚羟考酮和盐酸曲马多治疗妇科腹腔镜手术后早期疼痛的研究[J]. 中国临床药理学与治疗学, 2005, 10(2): 168-171.

不同剂量羟考酮缓解甲状腺术后气管拔管反应的比较

Comparison of responses induced by tracheal extubation between different doses of oxycodone after thyroidectomy

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 6

编辑推荐

Metrics

本文评价